Abstract:Résumé Contexte La médecine du travail a évolué depuis 1946, passant d'une approche individuelle axée sur l'aptitude professionnelle à une approche globale incluant la prévention des risques. Malgré les réformes visant à améliorer le dispositif français de prévention des risques professionnels, la fonte des effectifs de médecins du travail interroge fortement les modalités du suivi individuel des salariés. La loi de 2021 renforce la prévention en milieu de travail et introduit de nouvelles visites médicales sans pour autant faire évoluer certaines dispositions de la surveillance médicale existante. Dans ce contexte, une expérimentation a été menée autour de la participation renforcée d'infirmiers diplômés d'État en santé au travail (IDEST) dans le suivi de santé et de ses conditions (formation, protocolisation, réorganisation de l'ensemble de l'équipe pluridisciplinaire...). Méthodes Les IDEST de l'équipe ont été formés et accompagnés par le médecin du travail afin de réaliser des visites de pré-reprise, de reprise et des visites pré-SIR sous protocole. Les modalités de coopérations et les rôles au sein de l'équipe pluridisciplinaire ont également été ajustés en conséquence. Résultats Les IDEST ont réalisé un total de 326 visites dont 49 de pré-reprise, 27 de reprise, 44 à la demande du médecin et 206 pré-SIR. Sur l'ensemble de ces visites, neuf salariés ont été réorientés vers le médecin et dix ont nécessité un avis médical sans délai. L'assistante santé travail (AST) a réalisé 40 études de poste dans le cadre du maintien dans l'emploi en collaboration avec le médecin du travail et les IDEST. Conclusion La coopération entre les différents membres de l'équipe et leur implication dans le suivi de santé des salariés a permis de libérer près de 50 vacations médicales tout en s'assurant d'un suivi de santé de qualité. Ce temps médical a laissé la possibilité au médecin de travail de s'investir davantage dans la gestion des cas complexes et dans la prévention primaire. Summary Context Occupational medicine has evolved since 1946, shifting from an individual-focused approach centered on occupational fitness to a comprehensive approach that includes risk prevention. Despite reforms aimed at improving the French system for preventing occupational hazards, the declining number of occupational physicians raises significant questions about the methods for individual employee monitoring. The 2021 law strengthens workplace prevention and introduces new medical examinations, yet without necessarily changing certain provisions of the existing medical surveillance. In this context, an experiment was conducted to enhance the involvement of occupational health nurses in health monitoring and its conditions (training, protocolization, reorganization of the entire multidisciplinary team, etc.). Methods The occupational health nurses in the team were trained and guided by the occupational physician to conduct pre-return to work, return to work, and pre-SIR visits according to a protocol. The terms of cooperation and roles within the multidisciplinary team were also adjusted accordingly. Results The three occupational health nurses in the team conducted a total of 326 visits, including 49 pre-return visits, 27 return visits, 44 visits at the request of the occupational physician, and 206 pre-SIR visits. Out of all these visits, which used to be carried out solely by the occupational physician in the past, nine employees were referred to the physician and ten required immediate medical assessment. The occupational health assistant conducted 40 job analyses as part of job retention efforts in collaboration with the occupational physician and the occupational health nurses. Conclusion The cooperation among the various team members and their involvement in the employee health monitoring allowed for the release of nearly 50 medical appointments while ensuring high-quality health monitoring. This medical time freed up the occupational physician to become more engaged in managing complex cases and in workplace occupational risk prevention.

Evolution of drug consumption in a sample of French workers since 1986: the 'Drugs and Work' study

Evolution of work conditions for employees driving for work in France based on data from the 2003, 2010 and 2017 SUMER surveys (Surveillance Médicale des expositions aux risques Professionnels)

Trends in occupational disparities for exposure to carcinogenic, mutagenic and reprotoxic chemicals in France 2003-10

The French reporting system for drug shortages: description and trends from 2012 to 2018: an observational retrospective study

Addictive behaviors and healthcare renunciation for economic reasons in a French population-based sample

Eleven-year trends in socioeconomic inequalities in the prevalence and incidence of pharmacologically treated type 2 diabetes in France, 2010-2020

Antibiotic consumption in French nursing homes between 2018 and 2022: A multicenter survey

Trends in harmful drug exposure during pregnancy in France between 2013 and 2019: A nationwide cohort study

Évolution des pratiques en santé au travail au sein d'une équipe pluridisciplinaire

Evaluation of Medicine Abuse Trends in Community Pharmacies: The Medicine Abuse Observatory (MAO) in a Region of Southern Europe

Evolution of the profiles of new psychotropic drug users before and during the COVID-19 crisis: an original longitudinal approach through multichannel sequence analysis using the French health-care database

Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study

The epidemiology of adolescent drug use in France and Israel

First results of the French OCTOPUS survey among festival attendees: a latent class analysis

Party drug use in techno nights: a field survey among French-speaking Swiss attendees

Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases

Effects of a healthcare students' prevention intervention for school children on their own substance use: a before-after study

[Use of health services and treatments for major depressive episode in France]

Prevalence of occupational co-exposure to biomechanical factors and neurotoxic chemicals in French workers

Public and private sector responses to essential drugs policies: a multilevel analysis of drug prescription and selling practices in Mali

Trends in fatal poisoning among medical users of analgesics in France from 2013 to 2022: an analysis of the DTA register